Swedish Orphan Biovitrum AB (publ) BIOVF
51.05 USD +5.05 (+10.98%)
Nov 9, 2026, 2:56 PM EST
34.88 52-week range 51.05
- YTD
- +44.82%
- 1 year
- +46.36%
Altman Z-Score
3.52 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
B+3 / 5 overall
- DCF 4
- Return on Equity 4
- Return on Assets 4
- Debt / Equity 2
- P/E 2
- P/B 2
P/E 234×
P/S 4.0×
P/B 3.0×
P/FCF 13.2×
EV/EBITDA 11.2×
EV/Sales 4.3×
FCF Yield 7.6%
Gross Margin 43.6%
Operating Margin 28.5%
Net Margin 1.7%
ROE 1.3%
ROIC 14.0%
ROA 0.7%
Revenue 8.2%
Operating Income 42.7%
EPS (diluted) -87.7%
Free Cash Flow 94.0%
Current Ratio 0.9×
Quick Ratio 0.6×
Debt / Equity 0.3×
Net Debt / EBITDA 1.0×
Interest Coverage 9.7×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31